Protection from gastrointestinal diseases with the use of probiotics.
By P. Marteau, M. Vrese, C. Cellier, J. Schrezenmeir. American Journal of Clinical Nutrition, 2001
649 citations recorded by the source corpus.
Subfields: Food Science, Genetics, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/4cf1ebcea61599a696dca65352ac6f0730271415
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Food Science
In Genetics
In Infectious Diseases
Citations in the corpus
- Functional cultures and health benefits (2007, background): “Marteau et al. (2001) L. plantarum Especially effective in reducing inflammation in inflammatory bowel; e.g., enterocolitis in rats, small bowel bacterial overgrowth in children, pouchitis.”
- Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA (2004, background): “Paradoxically, nonpathogenic gut bacteria are also thought to contribute to immune homeostasis by altering microbial balance or by specifically interacting with the gut immune system, mechanisms purported to underlie the therapeutic basis for bacterial probiosis in inflammatory bowel diseas”
- Probiotics and their fermented food products are beneficial for health (2006, background): “boulardii decreased diarrhoea in irritable bowel syndrome, but was not effective in alleviating other symptoms of the syndrome (Marteau et al. 2001).”
- The current status and future focus of probiotic and prebiotic applications for salmonids (2010, background): “rhamnosus, have been demonstrated to reduce rotavirus and poliovirus infections in human patients (Marteau et al., 2001; de Vrese et al., 2005).”
- Bacteriocins and lactic acid bacteria - a minireview (2006, background): “LAB can be effective in preventing gastrointestinal disorders and in the recovery from diarrhoea of miscellaneous causes (Marteau et al., 2001).”
- Epidemiology of Invasive Mycoses in North America (2010, background): “cerevisiae subtype boulardii is also used in probiotic preparations for the prevention and treatment of various diarrheal disorders, such as those associated with enteral nutrition and Clostridium difficile infection (Herbrecht et al. 2005; Marteau et al. 2001).”
- Dietary prebiotics: current status and new definition (2010, background): “These health aspects have been summarised in the literature (Marteau et al. 2001, 2002; Fuller 1992, 1997; Naidu et al. 1999; Tannock 1999; Nobaek et al. 2000; de Vrese et al. 2001; D’Sousa et al. 2002; Wullt et al. 2003; Yamano et al. 2006; Sanders et al. 2007).”